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                                                                   ABSTRACT 
Examining change over time in the association between healthcare access on 
disparities in colorectal cancer mortality for minorities as compared to whites.                                                                          
BY  
                                                      Josephine Osaghae 
                                                      November 30th, 2017 
INTRODUCTION: Several studies have looked at the various factors that could explain the 
disparity in cancer diagnosis outcome including that for colorectal cancer between minorities and 
Whites. Studies have also shown that when it comes to insurance status Blacks and Hispanics are 
more likely to have higher uninsured rates. 3,1  With the implementation of the Affordable Care Act 
(ACA) in 2010 there has been a decline in the uninsured rate, with the rate of decline differing by 
state. 
AIM: This thesis examines whether the observed decline in CRC mortality rates observed 
nationally was comparable for minorities and whites in the 25 states with data for both groups.  
The questions that will guide the thesis:   
1)What association can be found between the expanded health care coverage for colorectal 
cancer screening following the ACA (2010) and colorectal cancer mortality? Does the disparity 
pattern in CRC mortality for minorities as compared to whites change after 2010?  
METHODS: This thesis uses state-level secondary data on colorectal cancer mortality from the 
period of 1990 to 2013 for 25 states in the United States which had data for White, Black and 
Hispanic populations. Data were provided each year by the National Vital Statistics System at the 
National Center for Health Statistics of the Centers for Disease Control and Prevention and the 
National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Access to 
care as measured by the uninsured rate for the 25 states derives from various sources and was not 
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available for each year. Two time periods were identified (early and later period) and mean 
mortality and insurance rates were calculated over these two intervals. Regression analysis was 
performed on the two-time intervals of data stacked over two periods (early and later periods), 
with a binary time indicator variable to differentiate the early and late periods. The regression 
included the CRC mortality rate for whites and the CRC mortality rates for Blacks and Hispanics for 
each state in each period (4 observations per state) as the dependent variable, a total of 100 
observations. Regressors included the uninsured rate for all populations in each time interval for 
each state (2 unique observations per state), an indicator of minority versus white race/ethnicity 
(50 observations=1, rest=0), and a time indicator (later time=1, earlier=0). The time and minority 
indicators were interacted to test whether minority CRC mortality rates fell after 2010 as 
compared to Whites, holding constant access to care (insurance status), the overall trend in CRC 
mortality, and the overall minority effect associated with CRC. Defining the time intervals as 
periods pre- and post- 2010, the main hypothesis was to assess whether these CRC mortality 
outcomes changed significantly pre-post the 2010 implementation of the ACA, and whether there 
were differential effects over time for minorities versus whites. 
RESULTS: Over both periods together, a higher state uninsured rate was associated with a higher 
state CRC mortality rate, but this was not statistically significant (p = 0.294). Over both periods 
together, the CRC mortality rate for Hispanics and Blacks was higher than that for whites, by 7.94 
deaths per 100,000, and this was statistically significant. There was a reduction in the average CRC 
mortality rate by 4.73 deaths per 100,000 over the time periods for everybody, and this was 
statistically significant (p = 0.000). However, in the later period, the Black and Hispanic CRC 
mortality rate fell by an additional 2.073 deaths per 100,000 as compared to the overall decline 
and this was significant (p = 0.035). Thus, there was a larger decline in the CRC mortality rate for 
Blacks and Hispanics compared to whites over the two periods, which suggests that the passage of 
the ACA may have reduced disparities in CRC mortality among minorities as compared to whites. 
DISCUSSION: Over the twenty-four-year period from 1990 to 2013, there was a steady decline in 
the CRC mortality rate for Blacks, Hispanics, and Whites. This thesis shows that the decline in 
mortality rate is weakly associated with a decline in uninsured rate, when comparing the average 
rates for both in 2009 and 2013, and not adjusting statistically for other factors. However, the 
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association between the uninsured rate and CRC mortality rate by race/ethnicity group remains 
unknown, because data on uninsured by each group was not available for all 25 states in the two-
time periods pre- and post- 2010. Also, not known is whether there was a change over time in the 
association between a state’s uninsured rates and the CRC mortality rates, which we could have 
ascertained using another time interaction with uninsured rates had these been available by 
group. Holding overall uninsured rate constant statistically in the model was necessary to 
disentangle the reduction in the minority CRC mortality rate as compared to Whites by the later 
period. Failure to hold uninsured rates constant statistically could have resulted in omitted 
variables bias on the minority effects, assuming that minority uninsured rates differed from 
whites. Future analyses should attempt to determine what if any insurance effects were present 
for the different groups. A three-way interaction between uninsured by group and time could also 
determine whether the insurance effects were stronger for one group than for another, which 
would have interesting policy implications. 
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                                                             INTRODUCTION 
Colorectal cancer (CRC) affects both men and women of all racial and ethnic groups and is the 
second- leading cause of death by cancer in the United States. 1 It is also the third most diagnosed 
cancer in the United States. 1,20 According to the Center for disease control (CDC), cancer is a 
disease condition in which the cells of the body grow out of control, and when this occurs in the 
colon or rectum it is referred to as colorectal cancer. In some instances, it begins as an abnormal 
growth called polyps within the inner lining of the colon or rectum, and if left over time these 
polyps could become cancerous. According to the American Cancer Society, Adenocarcinomas 
make up 95% of colorectal cancers, however few polyps are adenocarcinomas. Colorectal cancer is 
also one of the few cancers that there is screening available to find any abnormal growths in the 
colon and rectum, which can be removed before they become cancerous.  Screening can also be 
used to find colorectal cancer at an early stage,12,6 at which time treatment often leads to a cure, 
thus reducing the incidence and mortality from the condition.5,15 Based on this it is recommended 
(by several organizations, the American Cancer Society, the United States Preventative Task Force, 
and the CDC) that all adults 50 and over with an average risk be screened regardless of gender, 
race or ethnicity. 6,8 
According to the CDC One's risk of getting colorectal cancer increases with age with 90% of cases 
occurring in those 50 years or older.  It could also be found in younger people, especially those 
with a family history and risk factors which include Inflammatory bowel disease (Crohn’s disease 
or ulcerative colitis). Lifestyle factors such as lack of physical activity, being overweight or obese, a 
diet low in fruits and vegetables, or low-fiber and high-fat, alcohol consumption and tobacco use 
can increase risk. (These are factors often associated more with those of lower SES).6,19,28  
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Based on the data from the Cancer Statistics Working Group in 2013, 136,119 people in the United 
States were diagnosed with colorectal cancer, of which 71,099 were men and 65,020 women.33 
Based on statistics from the CDC in 2017, the deaths from colorectal cancer were 51,813 of which 
27,230 were men and 24,583 women. About nine in ten people whose colorectal cancers are 
found early and treated appropriately five years later are still alive. In 2014, 65.7% of U.S. adults 
were up-to-date with colorectal cancer screening; 7% had been screened but were not up-to-date, 
and 27.3% had never been screened.  
One of the factors that increases the likelihood of utilizing screening is affordability and access to 
care, and access is achieved through availability of health insurance or through Medicaid.26 
Without screening most colorectal cancers are diagnosed in the late stages resulting in higher 
mortality or lower survival rates.15,26 Despite the existence of an effective screening method there 
is still a disparity (relative to Whites) in those receiving such screening among certain 
subpopulations, such as Hispanics, American Indians, Alaskan Natives and those with a lower level 
of education and income level.27,5 
The incidence rates for colorectal cancer are greater for blacks compared to whites and lower for 
Hispanics as compared to both Whites and Blacks. 2,20,21 Similarly, the mortality rate for both 
Blacks and Hispanics is higher than that of Whites.20,2 Based on information from the American 
Cancer Society, the incidence of CRC amongst African-American males is 63.8 per 100,000, 
compared to 50.9 per 100,000 in White males.34 In older data (pre-2010), the mortality rates were 
also higher for African-American males at 29.4 per 100,000 compared to that of Whites being 19.2 
per 100,000.  A similar finding was also found for African-American females as compared to 
Whites, with the former having higher incidence and mortality rates.28 There have been several 
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innovative screening tools developed to diagnose and treat Colorectal cancer over the last three 
decades, which has resulted in early detection and longer survival times for those with these 
cancers, thus resulting in a declining mortality rate.21,6 However, irrespective of these innovations, 
if an individual has inadequate or no access to healthcare, their diagnosis of cancer is more likely 
to be made at a later stage, and thus they are more likely to have worse health outcomes and 
reduced survival time.21,3 Currently, the emphasis by most foundations and the Federal 
government is geared towards treatment innovations and screening.22  While treatment is 
important, there is a need for improved access to health care as well as targeted screening and 
other public health strategies for Blacks and Hispanics to improve their colorectal health 
outcomes.  
The Affordable Care Act (ACA) passed on March 23, 2010, was designed to increase coverage as 
well as improve the quality of the coverage.13,10,23 The increased coverage was achieved through a 
mandate that all private insurance cover CRC screening according to national guidelines free of 
charge, and the establishment of the exchange market place and the expansion of Medicaid.  
While the improved quality was by guaranteeing that all individuals have certain levels of 
accessibility to necessary health services, which included improved treatment options and 
preventive care without co-pays.13,10 Some studies have shown the effect of access to care on 
various subgroups, but with the implementation of the Affordable Care Act in 2010, this gives a 
clear-cut demarcation in time to be able to compare and assess the impact of increased access to 
health care coverage on colorectal cancer mortality, especially on those in the lower socio-
economic class by looking at states that expanded Medicaid.  Unfortunately, states lagged in their 
expansion efforts and this did not occur immediately following the 2010 Law. However, the 
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mandate that existing insurance cover CRC screening without charge went into effect immediately. 
The Purpose of the study is to show if there was an impact on the declining mortality rate of 
colorectal cancer in general, among Hispanics and Blacks as compared to whites following the 
implementation of the ACA.  A simple line chart (fig 1.1) of the annual colorectal mortality rate of 
Whites, Blacks and Hispanics, and the uninsured rate from 1990 to 2013 for all 25 states used for 
the analysis shows a continuous decline in the CRC mortality rate for both Blacks and Hispanics as 
well as Whites from 1990 to 2013, but with the CRC mortality rate for both Blacks and Hispanics 
being persistently higher than that of Whites throughout. Using the same data from the line chart, 
the gap in mortality rate between Blacks, Hispanics and Whites appears to be maintained annually 
as the rates decline, but then appears to narrow after 2010 (fig 1.2). The White CRC mortality rate 
declines and by 2008 is about at the level of the uninsured rate annually after that. This may imply 
that with increased access and affordability of screening there could be a narrowing and possibly 
elimination of the gap between Blacks, Hispanics and Whites. The trend analysis using the annual 
data from the 25 states from 1990 to 2013 for Whites, Blacks and Hispanics for ten years into the 
future to 2023 (fig 1.3), also shows that the Black and Hispanic CRC mortality rate continues to 
decline but still lags that of White CRC mortality decline, which gets into the single digits by 2023, 
but it shows a slight narrowing of the gap between Blacks and Hispanics as compared to whites 
after 2010, the year the ACA was passed. 
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FIG 1.1 
 
 
 
Fig 1.2 
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FIG 1.3 
 
 
This study will describe one of the factors that may be leading to the varying rate of decline for 
both minorities as compared to whites, and demonstrate if Black and Hispanic colorectal cancer 
survival rates vary by state; and any change in the decline in colorectal mortality rates for 
minorities compared to Whites after 2010. Minorities may still have higher rates, but is their rate 
falling relatively faster in the US as compared to whites? 
The study will answer the question; what association can be found between the expanded health 
care coverage for colorectal cancer screening following the ACA (2010) and colorectal cancer 
mortality? Does the disparity pattern in CRC mortality among whites and minorities change after 
2010?  
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CONCEPTUAL MODEL 
Fig 1.4     The cancer care continuum model, IOM (iom, 2013) 
 
 
Fig 1.5   A conceptual model for Black, Hispanic-White disparities in colorectal cancer incidence, 
screening, and outcomes. 
                                
 
                                  
    
 
*Only the domains from left side of the Cancer Care Continuum Model are included in this 
conceptual model. These are the domains relevant to this thesis. 
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CLINICAL 
OUTCOMES. 
Patient-level factor 
factor 
Provider-level 
factor factors 
System-level factor 
           CRC         
Prevention 
 
 
    CRC      
Detection 
CRC Diagnosis  
(stage of diagnosis) 
Left side of the colorectal care continuum 
                                          Types of cancer care 
19 
 
The conceptual model in this study is based on two frameworks as depicted in the IOM Source of 
Disparities in Care model (Fig 1.4) and the conceptual model for Black, Hispanic-White disparities 
in colorectal cancer incidence, screening, and outcomes (fig 1.5).  These frameworks have divided 
the source of racial disparities into the level of the patient, provider level and health care system-
level factors.35 Patient-level factors include attitudes towards preventive measures like CRC 
screening among different ethnic groups,28 and the patient preferences and demographic factors 
that determine whether a patient utilizes a particular health care service.  Another patient- level 
factor is the geographic location were the patient resides and how accessible health care providers 
are to that location. Provider-related characteristics are certain features specific to the techniques 
and practices of individual providers as well as the location of these providers, that could affect 
whether a patient receives a healthcare service.22 System-level contributors are the aspects of the 
healthcare system, such access and affordability of insurance or Medicaid expansion that affect a 
patient’s ability to access a health care service. The IOM Disparities in Care Model is not specific to 
a disease state or medical service. However, it is a hypothesis generating framework that can 
guide the exploration of any disparity. The Conceptual Model for Black, Hispanic-White Disparities 
in Colorectal Cancer Incidence, Screening, and Outcomes is a framework partly built on the IOM 
cancer care continuum model (Fig 1.5). The patient-level, provider-level, and system-level domains 
in the model interact with one another to influence patient and provider behavior and patient 
care. For example, an individual’s financial status, where they live and language barrier (patient-
level factor) may impact the healthcare system (system-level factor) he has access to, which, in 
turn, may determine the availability of CRC preventive and diagnostic services. Alternatively, a 
provider’s inclination to recommend a screening test to an eligible patient (provider-level factor) 
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may be influenced by system level factors such as reminders from the clinic due to inadequate 
reimbursement or request rejected or denied by insurance provider.25 
The disparities at the system-level will be the focus of this thesis as this would impact ones’ access 
to preventive measures, rate of detection, and diagnosis, as well as eventual treatment and thus 
survivorship and mortality rate of this cancer. Prevention of CRC is affected by one’s socio-
economic status. Among the risk factors for colorectal cancer is vitamin D deficiency. Vitamin D is 
one of the protectors against CRC as research has shown that there is a negative correlation 
between the amount of sunlight exposure and CRC mortality. With vitamin D diet deficiency, 
common amongst Americans, the sun is the best alternative source, and thus those living in the 
Metropolitan areas receive less sunlight due to the shadows from the high-rise buildings, 
compared to rural places.16,29 Darker skin is less able to absorb vitamin D than lighter skin, a 
reason hypothesized for greater cancer incidence among Blacks. Other socio-economic factors 
such as education, obesity and financial status which determines one's ability to afford access to 
preventive measures like screening, play a role in one’s outcome.16,29 
Detection disparities in either polyps (which could be precursors of CRC) or early stage CRC is 
another factor that could impact the outcome. The rate of colorectal screening and those factors 
which determine the rate at which each ethnic group has access to it, as well as their attitudes to 
screening would also affect the mortality rates. 
Finally, the diagnosis and treatment and the factors that influence these determine survivorship 
and mortality to CRC. The stage at which CRC is diagnosed would affect not only the treatment 
available, the cost of the treatment and ultimately survivorship and mortality. With later stage 
diagnosis, there is a likelihood of reduced survival chances.21,3 The system-level factor plays a 
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major role in CRC outcome as it affects one's ability to access the health care system in the first 
place.  
There is an interplay of the patient, provider and system-level factors on the prevention, 
detection, and diagnosis of CRC, as any disparity at the patient, provider or system-level would 
affect the prevention, diagnosis, and treatment of CRC and thus the survivorship and the mortality 
rate. Due to the limitation of the scope of this study in its inability to address the patient and 
provider level factors, this paper would be assessing the disparities at the system -level factors, 
which is access to care which for this paper is measured by the insured rate and thus what impact 
the uninsured rate has on Black and Hispanic CRC mortality compared to Whites CRC mortality 
rate. 
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METHODS AND PROCEDURES    
With the implementation of the Affordable care act(ACA) in 2010, it increased coverage for many 
who did not have coverage prior to its implementation. This was achieved through the creation of 
the exchanges with subsidies to assists with their premiums for those who qualify. Increased 
coverage was also achieved through the expansion of Medicaid by the states, except for 19 states 
mostly in the mid-west and south that did not expand.  The ACA also included an individual and 
employer mandate which further helped to increase coverage. In addition, preventive services 
such as cancer screening was mandated as part of all private insurance plane coverage without a 
co-pay, making it more affordable and accessible. 
With Blacks and Hispanics less likely to have insurance compared to Whites and thus less likely to 
be able to afford screening, thus their cancers being detected at later stages resulting in worse 
outcomes and higher mortalities3,9,15 With the increased coverage and access to colorectal 
screening from the ACA one would expect a narrowing of the gap in mortality rate between Blacks, 
Hispanics and White, since there is a disparity in both health coverage and access to screening 
there is a greater proportion of Blacks and Hispanics that could gain access to colorectal screening 
as compared to Whites.                                                                                                                                                              
The research is a non-experimental, cross-sectional study, and quantitative. This study used 
secondary data on colorectal cancer mortality from the period of 1990 to 2013 for 25 states in the 
United States which had data for White, Black and Hispanic populations. Mortality data provided 
each year by the National Vital Statistics System at the National Center for Health Statistics of the 
Centers for Disease Control and Prevention, also by the National Cancer Institute's Surveillance, 
Epidemiology, and End Results (SEER) Program. Population counts for denominators are based on 
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Census populations as modified by NCI. The data includes all races, ages, and sexes, with the 
minorities of interest defined as Blacks and Hispanics.  The uninsured rate for the 25 states derives 
from various sources, including literature review for years 1990 to 199632 and the United States 
Census Bureau 1999 for years 1997 to 1999 and United States Census Bureau 2013 for years 2000 
to 2013. The uninsured rate covered the years from 1990 to 2013 for the 25 states, and was made 
up of all ages, ethnic groups and both sexes.                                                                                                                           
Two time periods were identified (early and later period) and mean mortality and insurance rates 
were calculated over these two intervals. Regression analysis was performed on the two-time 
intervals of data stacked over two periods (early and later periods), with a binary time indicator 
variable to differentiate the early and late periods. The regression included the CRC mortality rate 
for whites and the CRC mortality rates for Blacks and Hispanics for each state in each period (4 
observations per state) as the dependent variable, a total of 100 observations. Regressors included 
the uninsured rate for all populations in each time interval for each state (2 unique observations 
per state), an indicator of minority versus white race/ethnicity (50 observations=1, rest=0), and a 
time indicator (later time=1, earlier=0). The time and minority indicators were interacted to test 
whether minority CRC mortality rates fell after 2010 as compared to Whites, holding constant 
access to care, the overall trend in CRC mortality, and the overall minority effect associated with 
CRC. Defining the time intervals as periods pre- and post- 2010, the main hypothesis was to assess 
whether these CRC mortality outcomes changed significantly pre-post the 2010 implementation of 
the ACA, and whether there were differential effects over time for minorities versus white 
race/ethnicity. All people of all races or ethnicities available in the SEER data were included.  
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The conceptual model for Black, Hispanic-White disparities in colorectal cancer incidence, 
screening, and outcomes (fig 1.2) was used.  This framework has divided the source of racial 
disparities into the level of the patient, provider level and health care system-level factors.35 
Patient-level factors include attitudes towards preventive measures like CRC screening among 
different ethnic groups,28 and the patient preferences and demographic factors that determine 
whether a patient utilizes a specific health care service, and the geographic location were the 
patient resides and how accessible health care providers are to that location. Provider-related 
characteristics are certain features specific to the techniques and practices of individual providers 
as well as the location of these providers, that could affect whether a patient receives a healthcare 
service.22 System-level factors are aspects of the healthcare system that affect a patient’s ability to 
access a health care service, such as access and affordability of insurance as well as Medicaid 
expansion that affect a patient’s ability to access a health care service. The Conceptual Model for 
Black, Hispanic-White Disparities in Colorectal Cancer Incidence, Screening, and Outcomes is a 
framework partly built on the IOM cancer care continuum model (Fig 1.4). The patient-level, 
provider-level, and system-level domains in the model interact with one another to influence 
patient and provider behavior and patient care. The thesis examined the system-level, which 
consists of aspects of the healthcare system geared towards access to it, and its affordability. The 
access to the healthcare system can be either through insurance coverage, Medicaid, Medicare or 
Tricare, and this determines one’s ability to take advantage of preventive measures such as 
colorectal screening. With the implementation of the ACA which included expansion of insurance 
coverage through premium assistance for those who qualify in the exchanges, along with Medicaid 
expansion. Therefor increasing access and affordability for many to the healthcare system, and 
with the mandated preventive measures such as colorectal screening without co-pay would also 
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increase its access.13,10,7 One possibility is that with more people having access to both the 
healthcare system and colorectal screening, and with more minorities initially without access prior 
to 2010, there is more room or a greater opportunity for a greater decline in the uninsured rate 
and a greater number having access to colorectal screening as compared to whites, thus a greater 
decline in minority CRC mortality compared to that of whites. The increased access to care and 
thus CRC screening may therefore result in a narrowing of the gap in the rate of decline in CRC 
mortality rate for minorities as compared to whites.                                                                                                                                  
The geographic information system (GIS) analysis and cartographic displays were performed with 
the software QGIS version 2.18.2, Geographic Coordinate Reference Systems WGS 84 (EPSG = 
4326) was used, with a scale of 1:11,401,397. Using the highest mean value for minority CRC 
mortality as the upper cutpoint as they had the highest value, a quantile classification scheme map 
series with five equal intervals and landscape for missing data was used to create maps for white 
and minority CRC mortality and uninsured pre - and post 2010 (figs 1.6, 1.7 and 1.8). The same 
cutpoint used across all maps makes the maps on CRC mortality for whites and minorities pre - and 
post 2010 comparable. 
The data from the 25 states with all three ethnic groups, CRC mortality rate divided into white and 
minority represented as Black and Hispanic is the dependent variable and Race, Time, race*time, 
and uninsured are independent variables. The white CRC mortality rate per 100,000 of all ages 
with a mean for the early period of 19.92/100,000 and sdev of 2.22, the minimum being 
17.42/100,000 and maximum of 23.40/100,000. The late period mean was 15.06/100,000 and 
sdev of 1.43, with a minimum of 12.00/100,000 and maximum of 17.85/100,000. The minority CRC 
mortality rate per 100,000 had in the early period a minimum of 21.94/100,000, a maximum of 
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32.33/100,000 and a mean of 27.87/100,000 with a sdev of 2.83. In the late period the minority 
CRC mortality rate had a minimum of 14.35/100,000, a maximum of 26.43/100,000 and a mean of 
20.92/100,000 with a sdev of 2.94.                                                                                                                            
A binary race indicator (MIN_DUM), which was from states with both Black and Hispanic data over 
the two periods was represented with a dummy indicator of 1, thus 50 observations and a 
minimum and maximum of 1 for both the early and late period, and a mean of 0.5 and sdev of 
0.51 for both periods as well.   The time indicator in years was represented as 0 if between 1990 
and 2009 (early period) and 1 if between 2010 and 2013 (later period), with 50 observations. The 
early period had a minimum, maximum, mean and sdev of 0, while the later period had a 
minimum and maximum of 1 and mean of 1 and sdev of 0.                                                                       
The uninsured rate also from the same 25 states as the CRC mortality and was per 100,000, had in 
the early period a minimum of 4.40/100,000, maximum of 26.10/100,000 and a mean of 
15.9/100,000 with sdev of 4.15. The later period minimum for the uninsured rate was 
3.70/100,000, maximum was 22.10/100,000 and mean 13.81/100,000 while the sdev was 3.9.                                             
The interaction between time and the binary race (Black and Hispanic) indicator, had 50 
observations, with a minimum, maximum, mean and sdev for the early period of 0, while the later 
period had a minimum of 0, maximum of 1, mean of 0.25 and sdev of 0.44. 
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Variable           Variable i.d         Coefficients         Standard error           t stat          P – value                                                 
White CRC                                                                                                                                                                     
mortality 
Black CRC          Intercept                 18.89                       1.09                    17.30             0.00                                                                                                                                                                                                                                 
mortality 
Minority                                                                                                                                                              
indicator             MIN_DUM              7.94                        0.69                   11.57              0.00 
Early and                                                                                                                                                           
later period          Time                     - 4.73                       0.70                   - 6.77               0.00 
Uninsured            Uninsured              0.07                       0.06                    1.06                0.29 
Interaction of                                                                                                                                                            
time period            time*DUM           - 2.07                     0.97                  - 2.14               0.04                                                                                                                                                              
& minority race 
Table showing regression analysis for two-time intervals of data stacked over two periods, number 
of observations 100, adjusted R square 0.78, interval 95%, p -value 0.05. 
*Data used was from 25 states of the United States which had CRC mortality and uninsured data 
available for Blacks, Hispanics and Whites. 
 
RESULTS 
      
 
  
                                                                                 Fig 1.6 
 
Black and Hispanic mortality rate 
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Fig 1.7                                                                                                                                                   
white mortality rate 
 
 
 
 
 
 
Fig 1.8  
Uninsured rate 
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Sample Summary statistics 
  
 
    
 
 
Variable 
variable 
description, 
including 
units of 
measurement 
 
Number 
 of 
observations 
    Early period  
     Per 100,000 
 
sdev 
early 
period 
    Later period 
     Per 100,000 
 
 
sdev 
later 
period 
min max mean min max mean   
 
 
White 
mortality 
(wm) 
Colorectal 
cancer 
mortality per 
100,000 for 
all ages for 
Whites in 25 
states 
 
 
 
50 
 
 
 
17.42 
 
 
 
23.4 
 
 
 
19.92 
 
 
 
2.22 
 
 
 
12 
 
 
 
17.85 
 
 
 
15.06 
 
 
 
1.43 
 
 
Black 
&Hispanic 
mortality 
(bhm) 
Colorectal 
cancer 
mortality per 
100,000 for 
all ages for 
Blacks and 
Hispanics 
combined in 
25 states 
 
 
 
 
50 
 
 
 
 
21.94  
 
 
 
 
32.33 
 
 
 
 
27.86 
 
 
 
 
2.83 
 
 
 
 
14.35 
 
 
 
 
26.43 
 
 
 
 
20.92 
 
 
 
 
2.94 
 
 
uninsured 
uninsured 
rate per 
100,000 for 
all races, 
gender and 
ages 
 
 
50 
 
 
4.40 
 
 
26.10 
 
 
15.9 
 
 
4.15 
 
 
3.70 
 
 
22.10 
 
 
13.81 
 
 
3.9 
           
 
 
uninsured 
uninsured 
rate per 
100,000 for 
all races, 
gender and 
ages 
 
 
25 
 
 
4.40 
 
 
26.10 
 
 
15.9 
 
 
  4.15 
 
 
3.70 
 
 
22.10 
 
 
13.81 
 
 
  3.9 
           
 
 
Number of 
observations 
mean early 
period per 
100,000 
 
SDEV 
early 
period 
mean later 
period per 
100,000 
SDEV later 
period 
 ages for 
Whites in 
25 states 
25 19.92  2.22 15.06 1.43 
Black &Hispanic mortality (bhm) 
Colorectal 
cancer 
mortality 
per 
100,000 
for all ages 
for Blacks 
and 
Hispanics 
25 27.86  2.83 20.92 2.94 
Table 1.1 
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Table 1.2 
 
 
 
 
 
 
 
 
 
 
The distribution of the Black and Hispanic CRC mortality rate by states in 2009(fig 1.6), shows a 
higher rate (23.3-32.3) across all the states except New York, Massachusetts and Connecticut 
which was (17.5 -23.3), this is also prior to the implementation of the ACA. By 2013 three years 
into the implementation of the ACA the CRC mortality rate across most of the states had dropped 
(17.5-23.6) except Oklahoma, Kansas, Arkansas, Tennessee, Mississippi, Alabama and Illinois which 
remained at (23.3 – 32.3), most of these states did not fully implement all aspects of the ACA.  
SUMMARY OUTPUT 
        
          Regression Statistics 
        Multiple R 0.888 
        R Square 0.789 
        Adjusted R 
Square 0.780 
        Standard Error 2.427 
        Observations 100 
        
          ANOVA 
         
  df SS MS F 
Significance 
F 
    Regression 4 2096.526 524.132 88.959 0.000 
    Residual 95 559.724 5.892 
      Total 99 2656.251       
    
          
  Coefficients 
Standard 
Error t Stat P-value Lower 95% 
Upper 
95% 
Lower 
95.0% 
Upper 
95.0% 
 Intercept 18.888 1.092 17.302 0.000 16.721 21.056 16.721 21.056 
 MIN_DUM 7.943 0.687 11.569 0.000 6.580 9.306 6.580 9.306 
 Time -4.730 0.698 -6.772 0.000 -6.116 -3.343 -6.116 -3.343 
 uninsured 0.065 0.061 1.055 0.294 -0.057 0.187 -0.057 0.187 
 time*DUM -2.073 0.971 -2.135 0.035 -4.001 -0.146 -4.001 -0.146 
 
 
        
          Regression Statistics 
        Multiple R 0.888414 
        R Square 0.78928 
        Adjusted R Square 0.780408 
        Standard Error 2.42731 
        Observations 100 
        
          ANOVA 
         
  df SS MS F 
Significance 
F 
    Regression 4 2096.526 524.1316 88.95895 0.000 
    Residual 95 559.7244 5.891836 
      Total 99 2656.251       
    
          
  Coefficients 
Standard 
Error t Stat P-value Lower 95% 
Upper 
95% 
Lower 
95.0% 
Upper 
95.0% 
 Intercept 18.88839 1.091677 17.30219 0.000 16.72114 21.05565 16.72114 21.05565 
 MIN_DUM 7.9426 0.686547 11.56891 0.000 6.579632 9.305568 6.579632 9.305568 
 Time -4.7297 0.698452 -6.7717 0.000 -6.1163 -3.3431 -6.1163 -3.3431 
 uninsured 0.064894 0.061497 1.055238 0.293993 -0.05719 0.18698 -0.05719 0.18698 
 time*DUM -2.0734 0.970924 -2.13549 0.035293 -4.00093 -0.14587 -4.00093 -0.14587 
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The distribution pattern for the Black and Hispanic CRC mortality rate pre-and post-2010 when the 
Affordable Care Act was implemented, had higher rates concentrated mostly in the southern 
states, these are mostly states that did not fully implement the ACA by not expanding Medicaid 
thus leaving a number of the working poor without insurance and most likely CRC screening,26 and 
Massachusetts having the lowest rate (0.00 – 5.8). It is not surprising Massachusetts has the 
lowest rate as they passed their health care law in 2005, thus expanding coverage. 
In 2009 the White CRC mortality rate across all 25 states was mostly between 17.5 -23.3 except for 
Oklahoma and Georgia that was between 11.6 – 17.5 (fig 1.8), and by 2013 only Arkansas was 
between 17-23.3 range, while Massachusetts was the lowest (0.00 - 5.8). 
 The data stacked over two periods regression analysis done showed that, over both periods 
together, a higher state uninsured rate was associated with a higher state CRC mortality rate, but 
this was not statistically significant (p = 0.294). Over both periods together, the CRC mortality rate 
for Hispanics and Blacks was higher than that for whites, by 7.94 deaths per 100,000, and this was 
statistically significant. There was a reduction in the average CRC mortality rate by 4.73 deaths per 
100,000 over the time periods for everybody, and this was statistically significant (p = 0.000). 
However, in the later period, the Black and Hispanic CRC mortality rate fell by an additional 2.073 
deaths per 100,000 as compared to the overall decline and this was significant (p = 0.035). Thus, 
there was a larger decline in the CRC mortality rate for Blacks and Hispanics compared to whites 
over the two periods, which suggests that the passage of the ACA may have reduced disparities in 
CRC mortality among minorities as compared to whites. 
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LIMITATIONS                                                                                                                                           
A major limitation was the lack of complete data for the uninsured rate for Blacks and Hispanics 
alone from 1990 to 2013 and that for Whites for the same period for all 50 states. Another 
limitation was the fact that only 25 states had CRC mortality data for Whites along with Blacks and 
Hispanics, thus limiting the size of data available to 100 instead of 300 had there been data from 
all 50 states for all three groups. 
The mortality rate and the uninsured rate data only included three years following the passage of 
the affordable care act (2010 -2013), so the full impact of the declining uninsured rate on CRC 
mortality could not be truly measured.  The findings may suggest that a lower uninsured rate is 
associated with a decline in the mortality rate. This decline was already occurring over the years 
from 1990, and there is not enough statistical information to yield statistically significant results 
tying uninsured rate to this decline. Another limitation is the lack of health insurance status by 
race or ethnicity in the states. 
Another limitation is that we are assuming the SEER data for CRC mortality is accurate, and the 
subject’s deaths are specific to CRC.  
Another limitation is the fact we had to hold uninsured rates constant as failure to do so could 
have resulted in omitted variables bias on the minority effects, assuming that minority uninsured 
rates differed from whites. Some variables known to affect survival such as treatment regimen, co 
morbidities, and risky behavior were not included, as these were found to affect the survival 
outcomes by other studies.27 
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Future analyses should attempt to determine what if any insurance effects were present for the 
different racial/ethnic groups. A three-way interaction between uninsured by group, and time 
could also determine whether the insurance effects were stronger for one group than for another, 
which would have interesting policy implications.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 
DISCUSSION                                                                                                                                                         
There has been a decline in the uninsured rate in the United States with each passing year, as 
shown by the United States Census Bureau. The findings from this study are consistent with that, 
though states that fully implemented the ACA showed a greater decline comparing data from 2009 
to that of 2013.7,10,13 Possibly due to the fact that CRC screening was more accessible in these 
states as well.26 
The current surveillance data shows that Blacks have a higher incidence rate for CRC compared to 
other races,2,20,21 while Hispanics have an earlier onset and more advanced disease as compared to 
other races.21 Now with Black and Hispanics being more likely to be uninsured3,1 and so having less 
access to affordable CRC screening. The reduced access to CRC screening for Blacks as compared 
to whites may be contributing to the persistent gap in CRC mortality decline before the 
implementation of the ACA. The study showed a reduction in the CRC mortality over time in 2013 
as compared to 2009 by 4.73/100,000 which was significant (p = 0.00), with a greater decline in 
minority CRC mortality by 2.073/100,000 as compared to whites over the two-time periods. Due to 
a greater number of minorities as compared to whites being uninsured, and thus are less likely to 
have access to CRC screening before the implementation of the ACA in 2010 (early period). It is not 
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surprising then that with the implementation of the ACA (later period) which may have made CRC 
screening more accessible with increased insurance coverage, minorities had a greater decline 
compared to whites. 
The stage at which the diagnosis of CRC is made impacts treatment options and outcomes,21 
therefore it is not surprising Blacks and Hispanics have a higher CRC mortality rate as compared to 
whites. The states with a higher uninsured rate and thus most likely reduced access to CRC 
screening for earlier detection were found to have higher minority CRC mortality rate in this study 
(23.3 – 32.3/100,000) compared to states with much lower uninsured rates. The states with much 
lower uninsured rates had minority CRC mortality rates ( 5.8 - 11.6) which were commensurate 
with that of whites (5.8 - 11.6). This was similar to the findings by other publications3,1 in which 
those without insurance had much later stages of CRC at diagnosis, and thus an expected higher 
mortality rate. 
This study thus suggests that the increased access to insurance and thus CRC screening by 
minorities did improve their CRC mortality rate. Now if the access to insurance and thus CRC 
screening amongst minorities is made commensurate to that for whites, this may reduce or 
eliminate the gap in CRC mortality rate decline for minorities as compared to whites.   
 
SUMMARY AND CONCLUSION 
The lower uninsured rate is weakly associated with a decline in mortality rate comparing the rates 
in 2009 with that of 2013. Over the twenty-four-year period from 1990 to 2013, there has been a 
steady decline in the CRC mortality rate for Blacks, Hispanics, and Whites.  
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There has also been a decline in the uninsured rate in 2013 as compared to 2009, with a greater 
decline in most of those states, that expanded Medicaid following the implementation of the ACA 
in 2010. The impact of the decline in the uninsured rate on CRC mortality rate is still uncertain due 
to there not being enough statistical information to yield statistically significant result and the 
short duration of its measurement. This is because the expansion of Medicaid in most states 
occurred within the last year or two of this data.  
Though there has been this decline in CRC mortality, that of Black and Hispanics still lag, compared 
to whites over the twenty-four years. The factors for the lag could be several, of which access to 
insurance was considered with this paper. Past publications had shown that increasing insurance 
coverage for Blacks did not necessarily improve their CRC outcome,18 but with greater awareness 
and access to screening this study has shown that this might not be the case. States with higher 
uninsured rates, most of which are the southern states appear to have a higher CRC mortality rate 
for Blacks and Hispanics as compared to those with a lower uninsured rate, mostly in the 
northeast. A case in point is Massachusetts with one of the lowest uninsured rate, the CRC 
mortality rate for Whites, Blacks and Hispanics is also one of the lowest and without the gap as 
that for Blacks and Hispanics track that of whites closely.  With Massachusetts, having 
implemented their health care law in 2006 thus resulting in more than 95% of the population 
being insured and thus having access to CRC screening giving more time for its impact to be seen, 
as compared to the ACA which was implemented in 2010 and the implementation of the Medicaid 
expansion aspect did not take effect till 2012. 
The decline in mortality rate has been put in motion long before the decline in uninsured rates 
occurred. This decline has been attributed to several other factors such as such as early detection 
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with better screening techniques, increased awareness amongst the general population and more 
advanced and effective treatment methods.30 Other factors explaining the decline is a change in 
diet, such as reduced consumption of cured and smoked meat, possibly resulting in lower 
carcinogenic nitrosamines exposure. The possible gastrointestinal microbiome or floral changes 
following the wide spread use of antibiotics, as in the case of decreasing Helicobacter pylori.  Also, 
playing a role may be the use of drugs like nonsteroidal anti-inflammatory including aspirin, 
hormone-replacement therapy, and statins, as these drugs have been associated with reduced 
colorectal neoplasia.30 
One thing remains, for one to access these new and improving treatment options as well as 
placement on antibiotics and so on, one needs to be able to access the health care system. To 
access the system, one's insurance status comes to play, this may account for the gap in mortality 
rate decline for Blacks and Hispanics as compared to Whites. Blacks and Hispanics persistently are 
more likely to be uninsured at higher rates compared to Whites.3,1  
Also, the stage at which a diagnosis of CRC was made also affects the mortality rate. Early 
detection results in better outcomes and those with insurance are thus more likely to present at 
earlier stages. Lack of insurance coverage for a long time has been linked to disparities in health 
and health care, including for the treatment of colorectal cancer.23 This study may point to the fact 
that when healthcare is accessible and affordable to more people they are more inclined to utilize 
the services available including preventive measures, such as CRC screening. 
In conclusion, the fact that there was a greater decline in the mortality rate for minorities as 
compared to Whites in the later period, may suggest that the passage of the ACA which not only 
increased access, but made screening a mandated coverage by insurance plans without co-pay 
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made a difference. The greater decline in CRC mortality for minorities as compared to whites may 
be due to the fact that in the first place there were more minorities uninsured and thus less likely 
to have access to preventive measures as compared to whites, giving more room for decline 
amongst this group.  It does appear race does have an impact on CRC mortality rate, with 
minorities faring worse.  
The current debate as to the fate of the ACA, repeal or not to repeal, and all the replacement 
options put forward by the party in control of Congress are geared towards reducing cost but in so 
doing would reduce the number of people insured, and nineteen states are yet to expand 
Medicaid. This debate keeps the chance of a further reduction in the number of uninsured and an 
increase in the number of people with access to preventive measures such as CRC screening in 
question.  Unfortunately, a majority of the non-expansion states are in the south, where a large 
proportion of Blacks and Hispanics reside. Thus, the disparity in insurance status, access to health 
care and colorectal cancer screening and thus mortality rate for CRC may not make a further 
change. 
If the ACA can remain, along with the mandated insurance coverage of preventive measures and 
screening without co-pays, with the remaining states expanding Medicaid, then the uninsured rate 
would be further reduced and access to screening increased.  Or if there is a replacement that 
further reduces the uninsured rate with eventual universal coverage. It would be helpful for 
further research to see what the long-term effect of universal coverage and increased access to 
colorectal screening, especially now with the use of cologuard, which is a less invasive method of 
screening, has on CRC mortality rate. To then assess if the gap between Black, Hispanic and White 
mortality rate continues to decline or is eliminated. 
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